Stock Ratings from Analyst Ratings Network

Open Main Menu Open Sidebar

Oncothyreon Company Profile (NASDAQ:ONTY)

Consensus Ratings for Oncothyreon (NASDAQ:ONTY) (?)
Ratings Breakdown: 1 Hold Rating(s), 3 Buy Rating(s)
Consensus Rating:Buy (Score: 2.75)
Consensus Price Target: $3.63 (6.93% upside)

Analysts' Ratings History for Oncothyreon (NASDAQ:ONTY)
Show:
DateFirmActionRatingPrice TargetActions
3/12/2015Jefferies GroupInitiated CoverageBuy$2.50View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/11/2015Cantor FitzgeraldReiterated RatingHold$4.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/21/2014HC WainrightInitiated CoverageBuy$4.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/21/2014WedbushInitiated CoverageBuy$4.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/19/2014WedbushLower Price Target$6.00 -> $3.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/14/2014Cantor FitzgeraldDowngradeBuy -> HoldView Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/13/2014Stifel NicolausBoost Price TargetBuy$3.00 -> $6.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/20/2013WedbushLower Price TargetOutperform$5.00 -> $3.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 5/29/2013 forward)